| 000 | 01865 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514190754.0 | ||
| 264 | 0 | _c20040930 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0888-0018 | ||
| 024 | 7 |
_a10.1080/08880010490277321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAksoylar, Serap | |
| 245 | 0 | 0 |
_aMeropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. _h[electronic resource] |
| 260 |
_bPediatric hematology and oncology _cMar 2004 |
||
| 300 |
_a115-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAmikacin _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
| 650 | 0 | 4 |
_aFever _xdrug therapy |
| 650 | 0 | 4 |
_aFungi _xisolation & purification |
| 650 | 0 | 4 |
_aGram-Negative Bacteria _xisolation & purification |
| 650 | 0 | 4 |
_aGram-Positive Bacteria _xisolation & purification |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfections _xmicrobiology |
| 650 | 0 | 4 | _aMeropenem |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aNetilmicin _xadministration & dosage |
| 650 | 0 | 4 |
_aNeutropenia _xdrug therapy |
| 650 | 0 | 4 |
_aPenicillanic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperacillin _xadministration & dosage |
| 650 | 0 | 4 | _aTazobactam |
| 650 | 0 | 4 |
_aThienamycins _xadministration & dosage |
| 700 | 1 | _aCetingül, Nazan | |
| 700 | 1 | _aKantar, Mehmet | |
| 700 | 1 | _aKarapinar, Deniz | |
| 700 | 1 | _aKavakli, Kaan | |
| 700 | 1 | _aKansoy, Savaş | |
| 773 | 0 |
_tPediatric hematology and oncology _gvol. 21 _gno. 2 _gp. 115-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/08880010490277321 _zAvailable from publisher's website |
| 999 |
_c14868914 _d14868914 |
||